NCT02811016View on ClinicalTrials.gov

Inhaled Budesonide and Acute Mountain Sickness

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions
Acute Mountain Sickness
Interventions
DRUG

Budesonide 200

200 µg inhaled at 7:00 a.m. and 7 p.m.

DRUG

Budesonide 800

800 µg inhaled at 7:00 a.m. and 7 p.m.

DRUG

Placebo

Placebo Inhalation at 7:00 a.m. and 7 p.m.

Trial Locations (1)

5020

Department of Anesthesiology, University Hospital, Salzburg

All Listed Sponsors
collaborator

University Hospital Heidelberg

OTHER

lead

Salzburger Landeskliniken

OTHER

NCT02811016 - Inhaled Budesonide and Acute Mountain Sickness | Biotech Hunter | Biotech Hunter